Sustained execution and high-impact data across HanchorBio's next-generation immuno-oncology portfolio to be featured at ASCO ...
Milestone validates the clinical potential of BSI-082 as a synergistic combination partner for antibody-drug conjugates (ADCs) and reinforces Biosion's In Global, For Global collaboration strategy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results